CASI Pharmaceuticals
CASI
#10181
Rank
C$25.92 M
Marketcap
C$1.26
Share price
8.63%
Change (1 day)
-74.05%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -C$61.08 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are C$31.56 Million. In 2024 the company made an earning of -C$52.43 Million a decrease over its 2023 earnings that were of -C$36.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$61.08 Million16.5%
2024 -C$52.43 Million44.35%
2023 -C$36.32 Million-29.55%
2022 -C$51.55 Million4.43%
2021 -C$49.36 Million-24.56%
2020 -C$65.43 Million4.74%
2019 -C$62.47 Million65.13%
2018 -C$37.83 Million155.07%
2017 -C$14.84 Million13.93%
2016 -C$13.02 Million31.18%
2015 -C$9.93 Million-72.5%
2014 -C$36.09 Million356.62%
2013 -C$7.91 Million-60.55%
2012 -C$20.03 Million218.41%
2011 -C$6.3 Million0.74%
2010 -C$6.25 Million-32.54%
2009 -C$9.26 Million-66.98%
2008 -C$28.04 Million-14.22%
2007 -C$32.68 Million7.04%
2006 -C$30.53 Million27.95%
2005 -C$23.87 Million4.51%
2004 -C$22.84 Million-15.84%
2003 -C$27.13 Million-55.29%
2002 -C$60.68 Million-34.05%
2001 -C$92.01 Million31.73%
2000 -C$69.84 Million31.56%
1999 -C$53.09 Million145.56%
1998 -C$21.62 Million76.4%
1997 -C$12.26 Million36.92%
1996 -C$8.96 Million